enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. IQVIA - Wikipedia

    en.wikipedia.org/wiki/IQVIA

    [28] [29] IMS Health shareholders received 0.384 shares of Quintiles common stock for each share of IMS Health common stock they held, leaving the split of ownership at 51.4% IMS and 48.6% Quintiles. [ 30 ] [ 31 ] The merger was completed in October and the resulting company was a $17.6 billion company called QuintilesIMS. [ 9 ]

  3. IMS Health - Wikipedia

    en.wikipedia.org/wiki/IMS_Health

    IMS stood for Intercontinental Medical Statistics. It was the largest vendor of U.S. physician prescribing data. [2] [3] [4] IMS Health was founded in 1954 by Bill Frohlich and David Dubow with Arthur Sackler having a hidden ownership stake. [5] In 2010, IMS Health was taken private by TPG Capital, CPP Investment Board and Leonard Green ...

  4. Ex-dividend date - Wikipedia

    en.wikipedia.org/wiki/Ex-dividend_date

    The ex-dividend date (coinciding with the reinvestment date for shares held subject to a dividend reinvestment plan) is an investment term involving the timing of payment of dividends on stocks of corporations, income trusts, and other financial holdings, both publicly and privately held.

  5. Get breaking Business News and the latest corporate happenings from AOL. From analysts' forecasts to crude oil updates to everything impacting the stock market, it can all be found here.

  6. Quintiles Announces Pricing of Initial Public Offering - AOL

    www.aol.com/2013/05/08/quintiles-announces...

    Quintiles Announces Pricing of Initial Public Offering Stock Expected to Begin Trading on NYSE May 9th RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- Quintiles today announced the pricing of its ...

  7. Quintiles Receives Award from Patient-Centered Outcomes ... - AOL

    www.aol.com/news/2013-06-04-quintiles-receives...

    Quintiles Receives Award from Patient-Centered Outcomes Research Institute to Compare the Effectiveness of Uterine Fibroid Treatments in Real-World Practice Study to help patients and clinical ...

  8. List of largest pharmaceutical mergers and acquisitions

    en.wikipedia.org/wiki/List_of_largest...

    Syngenta rejecteded another unsolicited offer from Monsanto, worth $45 billion, with management saying it undervalued the company and a merger would carry significant risks. Monsanto offered to acquire the company at a price of 449 Swiss francs per Syngenta share, with approximately 45% of the price paid in cash. [29] [30] 19 2014

  9. Quintiles Rated Industry Leader and Highest in Service ... - AOL

    www.aol.com/2013/05/21/quintiles-rated-industry...

    For premium support please call: 800-290-4726 more ways to reach us